MedTrace Logo

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group

NCT05754593 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-11-25

No results posted yet for this study

Summary

The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.

Conditions

Interventions

BIOLOGICAL

Anti-Mullerian hormone (AMH) level

Measure of Anti-Mullerian hormone (AMH) level by blood sample

OTHER

Antral follicle count (AFC)

Measure of Antral follicle count (AFC) by ultrasound imaging

OTHER

Clinical assessment

MS history and MS treatments and Expanded Disability Status Scale (EDSS) score will be recorded

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Valérie BERNARD, MD · University Hospital, Bordeaux

  • Antoine BERNARD, MD · University Hospital, Bordeaux

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-04
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05754593 on ClinicalTrials.gov